SEC Form 4
Latigo Biotherapeutics, Inc. (LTGO) insider trading
In the 12 months to Nov 19, 2026, 2 LTGO insiders reported open-market purchases of $5.0M across 2 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $5.0M
- 2 filings
Who traded LTGO, and when
- Purchase
LTGO daily close from Aug 7, 2026 to Nov 18, 2026, between $12.60 and $25.00, last $13.31. 0 sale and 2 purchase filings by 2 insiders, marked at their filing dates. Foresite Capital Fund V, L.P., 10% owner: bought $2.5M across 1 filing, first filed Aug 10, 2026, last Aug 10, 2026. James B. Tananbaum, Director: bought $2.5M across 1 filing, first filed Aug 10, 2026, last Aug 10, 2026.
Largest mark · tap a row for others
Foresite Capital Fund V, L.P. · 10% owner
Purchase $2,520,000
140,000 shares at $18.00 avg
Filed Aug 10, 2026
Close on filing date $18.56
Foresite Capital Fund V, L.P. · 10% owner
10% owner
$2.5M boughtJames B. Tananbaum · Director
Director
$2.5M boughtOpen-market trades
2 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Foresite Capital Fund V, L.P. | 10% owner | — | $2.5M | 1 | — | |
| James B. Tananbaum | Director | — | $2.5M | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Foresite Capital Fund V, L.P. 10% owner | Purchase | 140,000 | $18.00 | $2.5M | 2,008,024 | |
traded | James B. Tananbaum Director | Purchase | 140,000 | $18.00 | $2.5M | 2,008,024 |
GET /stocks/filings/vX/form-4?tickers=LTGO&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"LTGO"
],
"issuer_cik": "0002056611",
"owner_cik": "0001792204",
"accession_number": "0001104659-26-093580",
"form_type": "4",
"filing_date": "2026-08-10",
"period_of_report": "2026-08-10",
"issuer_name": "Latigo Biotherapeutics, Inc.",
"issuer_trading_symbol": "LTGO",
"owner_name": "Foresite Capital Fund V, L.P.",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-10",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 140000,
"transaction_price_per_share": 18,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 2008024,
"transaction_value": 2520000,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "See Footnote",
"footnotes": [
{
"id": "F3",
"description": "The securities are held of record by Foresite Capital Fund VI LP (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Tananbaum is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."
}
]
},
{
"tickers": [
"LTGO"
],
"issuer_cik": "0002056611",
"owner_cik": "0002013341",
"accession_number": "0001104659-26-093580",
"form_type": "4",
"filing_date": "2026-08-10",
"period_of_report": "2026-08-10",
"issuer_name": "Latigo Biotherapeutics, Inc.",
"issuer_trading_symbol": "LTGO",
"owner_name": "Foresite Capital Management VI LLC",
"is_director": false,
"is_officer": false,
"is_ten_percent_owner": true,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-10",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 140000,
"transaction_price_per_share": 18,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 2008024,
"transaction_value": 2520000,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "See Footnote",
"footnotes": [
{
"id": "F3",
"description": "The securities are held of record by Foresite Capital Fund VI LP (\"Fund VI\"). Foresite Capital Management VI, LLC (\"FCM VI\") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Tananbaum is the sole managing member of FCM VI and may be deemed to have sole voting and dispositive power over the securities held by Fund VI. Each of the Reporting Persons disclaims the existence of a \"group\" and disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 32 records
- Other32 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Latigo Biotherapeutics, Inc.'s CEO sold stock?
No. Todd N. Smith (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is LTGO’s insider data?
These are LTGO Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track LTGO insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for LTGO every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.